T-MG patients demonstrated significantly lower BAFF levels than the non-T-MG (respectively 671.2 ± 244.9 vs. 833.5 ± 302.4 pg/ml; p = 0.044). The gene discussed is TNFSF13B; the disease is myasthenia gravis.